Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0276640 (
TEM
)
20,729
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study focuses on the synthesis of nanocomposites named
CCA
and CZA that were prepared by the incorporation of cellulose (CL) in the Ca/Al and Zn/Al layered double hydroxide (LDH), respectively. These materials were then used for the uptake of As(III) and As(V) from aqueous medium. Characterization of both nanocomposites (
CCA
and CZA) was done using FTIR and Raman analysis to identify the functional groups, N
2
adsorption-desorption isotherms to determine the specific surface area and pore geometry and XPS analysis to obtain the surface atomic composition. Some other characters were investigated using simultaneous TGA and DTA and elemental chemical analysis (CHNS/O). The crystallinity of the prepared nanocomposites was displayed by XRD patterns. Furthermore, the sheet-like structure of the LDHs and the irregularity of surface morphology with porous structure were observed by
TEM
and SEM microphotographs. Optimization of maximum adsorption capacity was adjusted using different parameters including pH, contact time and adsorbent dosage. The pseudo-second-order model was in good fitting with kinetics results. The adsorption isotherm results showed that CZA exhibits better adsorption capacity for As(III) than
CCA
and the Langmuir isotherm model described the data well for both nanocomposites. Thermodynamic studies illustrated the endothermic nature of
CCA
and exothermic nature on CZA, as well as the fact that the adsorption process is spontaneous. A real water sample collected from well located in Gabes (Tunisia), has also been treated. The obtained experimental results were confirmed that these sorbents are efficient for the treatment of hazardous toxic species such as.
...
PMID:Synthesis of novel adsorbent by intercalation of biopolymer in LDH for the removal of arsenic from synthetic and natural water. 3217 74
Blood-brain barrier (BBB) disruption is a key event in triggering secondary damage to the central nervous system (CNS) under stroke, and is frequently associated with abnormal macroautophagy/autophagy in brain microvascular endothelial cells (BMECs). However, the underlying mechanism of autophagy in maintaining BBB integrity remains unclear. Here we report that in BMECs of patients suffering stroke, CLDN5 (claudin 5) abnormally aggregates in the cytosol accompanied by autophagy activation.
In vivo
zebrafish and
in vitro
cell studies reveal that BBB breakdown is partially caused by CAV1 (caveolin 1)-mediated redistribution of membranous CLDN5 into the cytosol under hypoxia. Meanwhile, autophagy is activated and contributes mainly to the degradation of CAV1 and aggregated CLDN5 in the cytosol of BMECs, therefore alleviating BBB breakdown. Blockage of autophagy by genetic methods or chemicals aggravates cytosolic aggregation of CLDN5, resulting in severer BBB impairment. These data demonstrate that autophagy functions in the protection of BBB integrity by regulating CLDN5 redistribution and provide a potential therapeutic strategy for BBB disorder-related cerebrovascular disease.
Abbreviations:
BBB: blood-brain barrier; BECN1: beclin 1; BMEC: brain microvascular endothelial cell; CAV1: caveolin 1;
CCA
: common carotid artery; CLDN5: claudin 5; CNS: central nervous system; CQ: chloroquine; HIF1A: hypoxia inducible factor 1 subunit alpha; MCAO: middle cerebral artery occlusion-reperfusion; OCLN: occludin; ROS: reactive oxygen species; STED: stimulated emission depletion; TEER: trans-endothelial electrical resistance;
TEM
: transmission electron microscopy; TJ: tight junction; TJP1: tight junction protein 1; UPS: ubiquitin-proteasome system.
...
PMID:Autophagy alleviates hypoxia-induced blood-brain barrier injury via regulation of CLDN5 (claudin 5). 3328 May